The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Research on PrEP safety for pregnant women and their babies finds no adverse effects – but knowledge gaps remain.
Study with transgender women suggests taking on-demand PrEP with hormone therapy may result in drug levels too low for HIV prevention.
The largest-ever study examining the effectiveness of condoms for anal sex finds remarkably low levels of failure, and calls to label their use in this way.
New World Health Organization policy indicates that countries should replace western blotting and line immunoassays, which can only be conducted in laboratories, with simpler methods such as rapid diagnostic tests.
Findings from France and Canada suggest it is safe to offer men who have sex with men a choice between daily and ‘on-demand’ PrEP if they are not having frequent sex.
The first global and regional estimates showing the link between herpes and HIV finds 30% of new HIV infections in 2016 were attributable to the STI.
Global analysis of death rates among women living with HIV during the first four years of antiretroviral treatment (ART) finds most deaths occur within three months – with some distinct regional variations.
To what extent do existing policies relating to age of consent for sexual reproductive health (SRH) services also affect PrEP access?
New technical guidance from the World Health Organization recognises effectiveness of event-driven PrEP for gay men following Prevenir study results.
New study finds treatment adherence a major challenge for excluded and hard to reach populations living with HIV, exacerbating existing health inequalities.
